Product Information
EPINEPHRINE 0.3 MG AUTO-INJECT is a generic product labeled by Viatris Specialty LLC, priced at $141.2757 per EA under NDC 49502010202. Its NADAC has been published 503 times since Feb 8, 2017.
FDA first approved this application on Dec 22, 1987. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.3 mg/.3mL
Manufacturer
Viatris Specialty LLCNDC
49502010202
Classification
Generic
Dosage Form
INJECTION
Route
INTRAMUSCULAR
Effective Date
9/23/2026
Active Ingredients
EPINEPHRINEApproval Type
Authorized Generic (NDA)
FDA Application
NDA019430FDA Approved
12/22/1987
TE Code
AB
On Market Since
12/15/2016
Pharmacological Classes
Price Statistics
The NADAC for EPINEPHRINE 0.3 MG AUTO-INJECT has been published 503 times since Feb 8, 2017, and over the history we have for it it has declined 22.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $141.2757 per EA |
|---|---|
| All-time high | $181.2307 (Feb 15, 2017) |
| All-time low | $139.9059 (Jul 19, 2023) |
| 52-week high | $142.2223 |
| 52-week low | $141.1397 |
| Median price | $142.4075 |
| Average price | $142.5937 |
| Largest weekly change | -20.5% (Mar 1, 2017) |
| Weeks tracked | 503 |
| Tracking since | Feb 8, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 5% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Viatris Specialty LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Epinephrine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Catecholamine class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of EPINEPHRINE 0.3 MG AUTO-INJECT?
The current National Average Drug Acquisition Cost (NADAC) for EPINEPHRINE 0.3 MG AUTO-INJECT, manufactured by Viatris Specialty LLC, is $141.2757 per EA (NDC 49502010202), effective Sep 30, 2026.
How has the price of EPINEPHRINE 0.3 MG AUTO-INJECT changed over time?
Over the history we have for it, the NADAC for EPINEPHRINE 0.3 MG AUTO-INJECT has declined 22.0%. It has been tracked across 503 weekly CMS publications since Feb 8, 2017.
What are the highest and lowest recorded NADAC prices for EPINEPHRINE 0.3 MG AUTO-INJECT?
Since Feb 8, 2017, the NADAC for EPINEPHRINE 0.3 MG AUTO-INJECT has ranged from a low of $139.9059 (Jul 19, 2023) to a high of $181.2307 (Feb 15, 2017), with a median of $142.4075 per EA.
Are there cheaper alternatives to EPINEPHRINE 0.3 MG AUTO-INJECT?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, EPINEPHRINE 0.3 MG AUTO-INJECT, is $133.5966 per EA — about 5% below EPINEPHRINE 0.3 MG AUTO-INJECT.
Who manufactures EPINEPHRINE 0.3 MG AUTO-INJECT?
EPINEPHRINE 0.3 MG AUTO-INJECT (NDC 49502010202) is labeled by Viatris Specialty LLC, and CMS classifies it as a generic product.